To read the full version of this content please select one of the options below:

US opioid medical liability rulings are coming

Tuesday, September 3, 2019

Significance

The case draws together some 2,000 lawsuits and comes as an Oklahoma court on August 26 fined pharmaceutical and medical equipment manufacturer Johnson & Johnson 572 million dollars for involvement in the US opioid painkiller addiction crisis.

Impacts

  • If the two cases succeed, medical liability lawsuits based on public health risks and costs are likely to increase.
  • Medical and biotech firms will try to push back against any increases in their liability regarding opioids and other drugs.
  • Opioids will still be medically essential, but market demand for them outside hospitals will likely diminish.
Expert Briefings Powered by Oxford Analytica
Stay up to date
Sign up to the Expert Daily Briefings email alert and receive up-to-the-minute analysis of global events as they happen.
*If your university does not have access to Expert Briefings, visit our information page to find out more.